imiquimod has been researched along with Lymphoma, B-Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, C; Fabbro, S; Hastings, J; Haverkos, B; Hwang, S; Johnson, A; Porcu, P; William, B | 1 |
| Bianchi, L; Campione, E; Chimenti, S; Citarella, L; Del Principe, I; Di Prete, M; Diluvio, L; Orlandi, A | 1 |
2 other study(ies) available for imiquimod and Lymphoma, B-Cell
| Article | Year |
|---|---|
Topical imiquimod monotherapy for indolent primary cutaneous B-cell lymphomas: a single-institution experience.
Topics: Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Lymphoma, B-Cell; Skin Neoplasms | 2020 |
Lack of efficacy of imiquimod in patients with basal cell carcinoma previously treated with rituximab for B cell lymphoma: two case reports.
Topics: Aminoquinolines; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Humans; Imiquimod; Lymphocyte Activation; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Rituximab; Stem Cell Transplantation; Treatment Outcome; Vincristine | 2016 |